Facts
- New York enacted a 1972 drug-control law to address diversion of prescription drugs into illegal channels.
- The law required prescriptions for Schedule II drugs to be written on an official triplicate form.
- One copy of each Schedule II prescription, including patient name, address, age, drug and dosage, prescriber identity, and dispensing pharmacy, had to be filed with the State Department of Health.
- The State stored these forms in a computerized data bank, retained them for five years under security measures, and then destroyed them.
- Public disclosure of patient identity was prohibited; access was limited to a small number of health department and investigatory personnel, with penalties for unauthorized disclosure.
- Patients receiving Schedule II drugs, prescribing physicians, and physician associations challenged the patient-identification and centralized storage requirements as unconstitutional.
- A three-judge federal district court enjoined enforcement, finding an overbroad invasion of privacy and faulting the State for not demonstrating a sufficient need for patient-identifying data.
- The State appealed directly to the U.S. Supreme Court.
Issues
- Whether compelled collection and centralized storage of identifiable Schedule II prescription information violates a constitutionally protected right of privacy under the Fourteenth Amendment.
- Whether the program’s potential disclosure risks or alleged deterrent effects on patients and physicians amount to an unconstitutional burden on protected liberty interests.
- Whether the State must prove the necessity of collecting patient-identifying information to sustain the statute’s constitutionality.
Decision
- The Supreme Court reversed and upheld the statute.
- The Court treated the law as a reasonable regulatory measure within the State’s police power to protect health and safety.
- The Court held that neither the existing operation nor the threatened impact of the program established a constitutionally significant invasion of privacy.
- The Court rejected the view that a failure to prove necessity, as found by the district court, was sufficient to invalidate the statute.
- The Court found the statutory confidentiality limits and security safeguards adequate to reduce disclosure risks to a constitutionally permissible level.
- Concurring opinions emphasized that different, more intrusive data-collection schemes could present distinct constitutional questions.
Legal Principles
- The Constitution recognizes privacy-related interests that include (1) avoiding disclosure of personal matters and (2) independence in certain important personal decisions.
- Government collection and retention of sensitive personal information does not necessarily violate the Fourteenth Amendment when the program serves legitimate public purposes and includes meaningful confidentiality and security protections.
- Courts generally evaluate informational-privacy claims by considering the character of the information collected, the governmental interests served, the extent of dissemination risk, and the safeguards limiting access and disclosure.
- A statute is not unconstitutional merely because a court considers the government’s chosen means broader than necessary; the absence of proven necessity does not alone establish a due process violation.
Conclusion
The Court upheld New York’s requirement that Schedule II prescriptions include patient-identifying information filed in a state database, concluding that the program’s public health and law-enforcement aims, combined with limits on access and disclosure, did not amount to an invasion of privacy protected by the Fourteenth Amendment.